Cigna Corp (CI)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 3,434,000 | 3,039,000 | 3,708,000 | 3,620,000 | 5,164,000 | 5,304,000 | 6,653,000 | 6,750,000 | 6,680,000 | 6,627,000 | 5,491,000 | 5,401,000 | 5,365,000 | 8,384,000 | 8,151,000 | 8,438,000 | 8,458,000 | 5,300,000 | 5,263,000 | 4,917,000 |
| Total stockholders’ equity | US$ in thousands | 41,033,000 | 42,095,000 | 41,332,000 | 41,181,000 | 46,223,000 | 45,691,000 | 45,445,000 | 44,502,000 | 44,872,000 | 45,041,000 | 45,892,000 | 46,087,000 | 47,112,000 | 47,415,000 | 48,709,000 | 48,149,000 | 50,321,000 | 48,032,000 | 47,366,000 | 45,079,000 |
| ROE | 8.37% | 7.22% | 8.97% | 8.79% | 11.17% | 11.61% | 14.64% | 15.17% | 14.89% | 14.71% | 11.97% | 11.72% | 11.39% | 17.68% | 16.73% | 17.52% | 16.81% | 11.03% | 11.11% | 10.91% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $3,434,000K ÷ $41,033,000K
= 8.37%
ROE, or return on equity, is a key financial ratio that measures a company's profitability by evaluating how effectively it generates profit from its shareholders' equity. The ROE for Cigna Corp has fluctuated over the provided periods, ranging from a low of 7.22% on September 30, 2024, to a high of 17.68% on September 30, 2021.
The trend in Cigna Corp's ROE shows some variability but generally demonstrates an upward trajectory from the end of 2020 to the third quarter of 2022, followed by a decline thereafter. The company experienced a significant increase in ROE from December 31, 2020, to March 31, 2021, showing improved profitability during that period. Subsequently, the ROE fluctuated around the high teens in 2021 before a gradual decline in 2023 and 2024.
The fluctuations in Cigna Corp's ROE could be attributed to various factors such as changes in operating efficiency, levels of profitability, debt management, or changes in shareholder equity. It is crucial for investors and stakeholders to closely monitor ROE trends to assess the company's financial performance and management effectiveness. The declining trend in ROE towards the end of the provided period may indicate challenges in sustaining profitability or optimizing the use of equity capital. Further analysis of the company's financial statements and business operations would be necessary to provide a more detailed understanding of the factors affecting Cigna Corp's ROE.
Peer comparison
Dec 31, 2024